Indeed, cell culture studies by Sabbagh et al. (2018) showed that pharmacological disruption of the FKBP5/GR complex led to a restoration of effects of DEX on GR activity and its translocation from the cytoplasm to the nucleus in primary neurons and M17 neuroblastoma cells. This evidence concerns the gene NR3C1 and neuroblastoma.